Effects of Therapeutic Antibodies on Gene and Protein Signatures in Asthma Patients: A Comparative Systematic Review
Several biologic therapies that target inflammatory modulators are now used for treating patients with uncontrolled, severe asthma. Knowledge about how this type of treatment modifies the molecular milieu is rapidly increasing. Thus, this systematic review aimed to compile the reported effects of th...
Main Authors: | Maria J. Martin, Miguel Estravís, Asunción García-Sánchez, Jacqueline Pérez-Pazos, María Isidoro-García, Ignacio Dávila, Catalina Sanz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/2/293 |
Similar Items
-
Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma
by: AlShareef S, et al.
Published: (2022-02-01) -
Anaphylaxis to three humanized antibodies for severe asthma: a case study
by: Koichi Jingo, et al.
Published: (2020-06-01) -
Evidence-Based Approach of Biologic Therapy in Bronchial Asthma
by: Adnan Liaqat, et al.
Published: (2023-06-01) -
Elaborate biologic approval process delays care of patients with moderate-to-severe asthma
by: Esha Sehanobish, PhD, et al.
Published: (2023-05-01) -
Characterization of Severe Uncontrolled Asthma in Japan: Analysis of Baseline Data from the PROSPECT Study
by: Koya T, et al.
Published: (2023-06-01)